Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
|
US |
|
S
|
San Miguel Corp
XPHS:SMC
|
PH |
|
T
|
Tandy Leather Factory Inc
NASDAQ:TLF
|
US |
|
A
|
American Campus Communities Inc
F:FGA
|
US |
|
Rotork PLC
LSE:ROR
|
UK |
|
9 Spokes International Ltd
ASX:9SP
|
NZ |
|
Beyaz Filo Oto Kiralama AS
IST:BEYAZ.E
|
TR |
Wall Street
Price Targets
RIGL Price Targets Summary
Rigel Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
RIGL
is 52.22 USD
with a low forecast of 38.38 USD and a high forecast of 74.55 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is RIGL's stock price target?
Price Target
52.22
USD
According to Wall Street analysts, the average 1-year price target for
RIGL
is 52.22 USD
with a low forecast of 38.38 USD and a high forecast of 74.55 USD.
What is Rigel Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
7%
For the last 14 years the
compound annual growth rate for
Rigel Pharmaceuticals Inc's revenue is
34%.
The projected
CAGR
for the next 3 years is
7%.
What is Rigel Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
-3%
The
compound annual growth rate
of Rigel Pharmaceuticals Inc's operating income for the next 3 years is
-3%.
What is Rigel Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
-37%
The
compound annual growth rate
of Rigel Pharmaceuticals Inc's net income for the next 3 years is
-37%.
